Tandem Diabetes Care

Tandem Diabetes Care is a medical device company with an innovative, user-centric and integrated approach to the design, development, and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells a family of insulin pump products, which includes the t:slim X2™ Insulin Pump, the next-generation color touchscreen pump, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity.

Revenue(FY, 2017)

$107.6 M

Market capitalization(2018-04-25)

$41.2 M

Devices Sold(FY, 2016)

50 K

Type

Public

San Diego, US

Founded

2006

Size (employees)

591 (est)

Website

tandemdiabetes.com

Tandem Diabetes Care was founded in 2006 and is headquartered in San Diego, US

Report incorrect company information

Key People/Management at Tandem Diabetes Care

Kim D. Blickenstaff

President , CEO & Board Of Director

John Cajigas

CFO

Jim Leal

VP, Operations

Bob Anacone

EVP and Chief Commercial Officer

Susan Morrison

VP, HR, Corporate & Investor Relations

Report incorrect company information

Tandem Diabetes Care Office Locations

Tandem Diabetes Care has an office in San Diego

San Diego, US (HQ)

11045 Roselle St

Show all (1)

Report incorrect company information

Tandem Diabetes Care Financials and Metrics

Tandem Diabetes Care Financials

Tandem Diabetes Care's revenue was reported to be $107.60 m in FY, 2017

Summary

USD
Revenue (FY, 2017)	107.6 m
Gross profit (FY, 2017)	44.1 m
Gross profit margin (FY, 2017), %	41%
Net income (FY, 2017)	(73 m)
EBIT (FY, 2017)	(62.9 m)
Market capitalization (25-Apr-2018)	41.2 m
Cash (31-Dec-2017)	13.7 m

Tandem Diabetes Care's current market capitalization is $41.2 m.

Income Statement

Annual

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Revenue	49.7 m	72.9 m	84.2 m	107.6 m
Revenue growth, %		47%	16%
Cost of goods sold	34.5 m	46.3 m	60.7 m	63.5 m
Gross profit	15.2 m	26.6 m	23.6 m	44.1 m

Quarterly

USD	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017
Revenue	15.7 m	15.7 m	20.1 m	23 m	12.3 m	19 m	21.3 m	27 m
Cost of goods sold	10.9 m	10.2 m	13.1 m	14.8 m	13.9 m	12.2 m	13.3 m	15.1 m
Gross profit	4.8 m	5.5 m	6.9 m	8.2 m	(1.6 m)	6.8 m	8 m	11.9 m
Gross profit Margin, %	31%	35%	35%	36%	(13%)	36%	38%	44%

show all

Balance Sheet

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Cash	31.2 m	43.1 m	44.7 m	13.7 m
Accounts Receivable	7.7 m	14.1 m	11.2 m	20.8 m
Inventories	11.9 m	17.5 m	21.2 m	27 m
Current Assets	90.8 m	107 m	92.1 m	64.2 m

show all

Cash Flow

Annual

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Net Income	(79.5 m)	(72.4 m)	(83.4 m)	(73 m)
Depreciation and Amortization	4.4 m	4.8 m	5.5 m	6.9 m
Inventories	(1.8 m)	(6.1 m)	(6.9 m)
Accounts Payable	(1.2 m)	3.4 m	3.2 m	(2 m)

Quarterly

USD	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017
Net Income					(19.5 m)	(19.6 m)	(20.5 m)	(18.3 m)	(29.8 m)	(23.8 m)
Inventories	10.2 m	11.1 m	11.9 m		14.7 m	17.6 m	20.2 m	21.7 m	22.9 m
Accounts Payable	2.1 m	2.5 m	3 m	4.1 m	4 m	4 m	6 m	6.8 m	5.6 m	4.9 m	6.6 m	7.6 m